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https://doi.org/10.1016/j.celrep.2020.107579SUMMARYPolyunsaturated fatty acids (PUFAs) confer health benefits by preventing inflammation and obesity and by
increasing thermogenesis in brown and beige adipocytes. As well as being supplied exogenously as nutri-
ents, PUFAs are largely stored in membrane glycerophospholipids and released by phospholipase A2s
(PLA2s). However, the molecular identity of the PLA2 subtype(s) that supplies endogenous PUFAs for meta-
bolic homeostasis remains unclear. Here we show that PLA2G2D, a secreted PLA2 isoform, is constitutively
expressed in M2-type macrophages in white adipose tissue (WAT) and shows a reciprocal correlation with
obesity. Studies using global and macrophage-specific Pla2g2d-deficient mice reveal that PLA2G2D in-
creases energy expenditure and thermogenesis by facilitating adipocyte browning, thereby ameliorating
diet-induced obesity, insulin resistance, and WAT inflammation. Mechanistically, PLA2G2D constitutively
supplies a pool of PUFAs, u3 in particular, in WAT. Thus, our present findings underscore the contribution
of the macrophage-driven PLA2G2D-u3 PUFA axis to metabolic health.INTRODUCTION
Metabolic syndrome is increasing at an explosive rate worldwide
due to a pandemic of obesity, insulin resistance, and type 2 dia-
betes (Brestoff and Artis, 2015; Olefsky and Glass, 2010). White
adipose tissue (WAT) is a principal lipid storage organ, whereas
brown adipose tissue (BAT) consumes fuels for thermogenesis,
thereby improving systemic metabolism (Lee et al., 2015; Uhm
and Saltiel, 2015). Beige adipocytes, which are induced in
WAT through a process termed ‘‘browning,’’ have recently
been attracting attention as another class of adipocytes that pro-
mote adaptive thermogenesis in response to cold exposure,
physical exercise, and dietary intervention (Boström et al.,
2012; Harms and Seale, 2013; Hui et al., 2015; Lee et al., 2015;
Roberts et al., 2014; Rosenwald et al., 2013; Suárez-Zamorano
et al., 2015). Accordingly, activation of brown and beige adipo-
cytes could be an attractive therapeutic strategy against obesity
and related metabolic complications (Hanssen et al., 2015).
Whereas adipose tissue inflammation with recruitment of inflam-
matory cells including M1-type macrophages is tightly linked to
insulin resistance, M2-type macrophages in concert with type 2
immunity attenuate obesity-associated inflammation and assistThis is an open access article undadipocyte browning, thereby exerting a beneficial impact on
metabolism (Nguyen et al., 2011; Qiu et al., 2014; Rao et al.,
2014). However, the mechanism whereby M2-type macro-
phages promote adipocyte browning still remains incompletely
understood.
The quality of lipids is a critical determinant of various biolog-
ical responses including metabolic diseases. Sustained eleva-
tion of saturated fatty acids (SFAs), such as palmitic acid
(C16:0), causes lipotoxicity leading to chronic inflammation
and insulin resistance, whereas unsaturated fatty acids counter
this process by increasing membrane fluidity, acting as lipo-
kines, or interacting with lipid-sensing receptors (Cao et al.,
2008; Holzer et al., 2011). Arachidonic acid (AA; C20:4), an u6
polyunsaturated fatty acid (PUFA), is metabolized to a class of
lipid mediators (called eicosanoids) including prostaglandins
(PGs) and leukotrienes (LTs), which diversely affect inflammation
andmetabolism (Li et al., 2015; Vegiopoulos et al., 2010).u3 PU-
FAs, including eicosapentaenoic acid (EPA; C20:5) and docosa-
hexaenoic acid (DHA; C22:6), serve as precursors of anti-inflam-
matory lipid mediators such as resolvins and protectins (Serhan,
2014), and also act by themselves as ligands for fatty-acid-
sensing plasma membrane (e.g., GPR120) and nuclear (e.g.,Cell Reports 31, 107579, May 5, 2020 ª 2020 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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which improve metabolic homeostasis not only by attenuating
adipose tissue inflammation but also by promoting adipocyte
browning and thereby thermogenesis (Ichimura et al., 2012; Oh
et al., 2010, 2014; Quesada-López et al., 2016; Syed et al.,
2018; Yan et al., 2013). Moreover, recent studies have identified
unusual fatty acidmetabolites that control the thermogenic func-
tion of brown and beige adipocytes (Kim et al., 2017; Long et al.,
2016; Lynes et al., 2017).
In a physiological state, a large fraction of PUFAs are incorpo-
rated into the sn-2 position of membrane phospholipids and
released by phospholipase A2 (PLA2) enzymes (Murakami,
2017). Besides several intracellular PLA2s or related lipases
that have been implicated in metabolic regulation (Haemmerle
et al., 2006; Mancuso et al., 2010; Peña et al., 2016; Tian et al.,
2010), secreted PLA2s (sPLA2s) have recently emerged as a
class ofmetabolic coordinators that canmanipulate extracellular
phospholipid metabolism in response to given microenviron-
mental cues. PLA2G1B (sPLA2-IB), a ‘‘digestive sPLA2,’’ is
secreted from the pancreas into the intestinal lumen, where it
digests dietary and biliary phosphatidylcholine (PC) to produce
lysophosphatidylcholine (LPC), which promotes obesity and in-
sulin resistance following prandial absorption (Labonté et al.,
2010). PLA2G5 (sPLA2-V) and PLA2G2E (sPLA2-IIE), two ‘‘meta-
bolic sPLA2s,’’ are induced in hypertrophic white adipocytes
during obesity and distinctly regulate systemic metabolism by
acting on different phospholipids in lipoproteins (Sato et al.,
2014). However, the identity of the particular PLA2 subtype(s)
that endogenously supplies free PUFAs in adipose tissue for
metabolic regulation remains unknown.
PLA2G2D (sPLA2-IID) is expressed abundantly in the spleen
and lymph nodes and attenuates Th1 and Th17 immune re-
sponses by mobilizing anti-inflammatory u3 PUFA metabolites
(Miki et al., 2013, 2016). Interestingly, a polymorphism in the hu-
man PLA2G2D gene is linked to body weight changes in patients
with chronic lung disease (Takabatake et al., 2005). Moreover,
our recent microarray analysis using mouse WAT has revealed
that, along with the upregulated sPLA2s (PLA2G5 and
PLA2G2E), PLA2G2D is found to be one of the most downregu-
lated lipases during the onset of obesity (Sato et al., 2014),
suggesting a potential contribution of PLA2G2D to metabolic
regulation. Here we show that PLA2G2D is enriched in M2-
type macrophages in WAT, promotes adipocyte browning,
puts a brake on adipose tissue inflammation, and thereby coun-
teracts diet-induced metabolic disorders by supplying a pool of
PUFAs, u3 in particular, with subsequent metabolic benefits.
Thus, this study has identified a particular PLA2 that lies up-
stream of the u3 PUFA receptor GPR120 (fatty acid receptor 4)
in the context of metabolic regulation.
RESULTS
M2-type Macrophages in WAT Constitutively Express
PLA2G2D
Heatmap visualization of the expression of lipase-related genes
in visceral WAT (vWAT) of C57BL/6mice fed a high-fat diet (HFD;
CLEA high-fat diet 32 [fat calorie 60%]) in comparison with those
fed a standard low-fat diet (LFD; CLEA rodent diet CE-2 [fat2 Cell Reports 31, 107579, May 5, 20204.8%]) for 20 weeks (GEO: GSE56038) revealed that Pla2g2d
was one of the most downregulated lipases in obese vWAT (Fig-
ure S1A) (Sato et al., 2014). Quantitative RT-PCR confirmed that,
in addition to lymphoid organs (Miki et al., 2013, 2016), Pla2g2d
was substantially detected in vWAT of LFD-fed mice and
decreased after HFD feeding, whereas its expression was very
low in BAT, heart, liver, and skeletal muscle regardless of diet
(Figure 1A). This expression pattern of Pla2g2d in vWAT was in
contrast to that of Pla2g2e and Pla2g5, whose expression levels
were low on an LFD and markedly induced after HFD feeding
(Figure 1B). Indeed, under LFD conditions, Pla2g2d is a major
sPLA2 expressed in vWAT and more abundantly in subcutane-
ous WAT (sWAT), and its steady-state expression in vWAT of
LFD-fed mice was comparable to the induced expression of
Pla2g2e and Pla2g5 in HFD-fed mice (Figures 1B, 1C, and
S1B). Moreover, Pla2g2d expression in vWAT and sWAT was
markedly lower in genetically obese ob/ob mice than in control
mice (Figure 1C).
When vWAT was separated into adipocytes and the stromal
vascular fraction (SVF), Pla2g2d expression was exclusively en-
riched in the SVF and decreased after HFD feeding for
20 weeks (Figure 1D). Further sorting of SVF cells into
Sca1+CD11bCD45 preadipocyte-rich andSca1CD11b+CD45+
hematopoietic cell-rich fractions revealed that Pla2g2d was ex-
pressed mainly in the latter (Figures 1E and S1C). After sorting of
F4/80-gated macrophages within the SVF, Pla2g2d expression
was distributed in CD11cloCD206hi M2-like macrophages in
marked preference to CD11chiCD206lo M1-like macrophages
and decreased after HFD feeding (Figures 1F and S1D). In agree-
ment, immunoreactive PLA2G2D protein was located almost
exclusively in F4/80+CD206+ macrophages in vWAT (Figure 1G).
Moreover, when macrophage colony-stimulating factor (M-CSF)-
driven bone-marrow-derived macrophages (BMDMs; M0, which
is M2 like) were polarized into M1- or M2-type macrophages
ex vivo by interferon-g (IFN-g) + lipopolysaccharide (LPS) and inter-
leukin-4 (IL-4), respectively, Pla2g2d was expressed in the order
M2 > M0 > M1 (Figure 1H). Proper polarization of BMDMs to M1-
and M2-type macrophages in this setting was validated by the
expression of their signature markers Nos2 and Cd206, respec-
tively (Figure S1E). Furthermore, Pla2g2d expression in BMDMs
was decreased after treatment with palmitic acid (Figure 1I), an
SFA that promotes M1 polarization of macrophages (Figure S1F).
These results indicate that PLA2G2D is enriched in M2-type mac-
rophages in WAT of lean mice and downregulated during the pro-
cess of obesity.
Exacerbated Diet-Induced Obesity and Insulin
Resistance in HFD-Fed Pla2g2d/ Mice
To assess the role of PLA2G2D in diet-induced obesity, we
placed Pla2g2d–/– mice (Miki et al., 2013) and their littermate
controls on an HFD. We found that obesity and weight gain
were significantly greater in HFD-fed Pla2g2d/ mice than in
Pla2g2d+/+ mice (Figures 2A and 2B), despite similar food intake
between the genotypes (Figure S2A). The proportions of total,
visceral, and subcutaneous fats (Figure 2C) and adipocyte size
in vWAT (Figures 2D and S2B) were significantly greater in
Pla2g2d–/– mice than in Pla2g2d+/+ mice after HFD feeding for
20 weeks. Plasma levels of leptin (Figure 2E) and insulin
Figure 1. Pla2g2d Is Expressed in M2 Macrophages in WAT
(A and B) Quantitative RT-PCR ofPla2g2dmRNA in various tissues (A) and various sPLA2mRNAs in vWAT (B) fromC57BL/6 mice fed an LFD (n = 4) or HFD (n = 5)
for 20 weeks. Expression levels were normalized against Gapdh. LN, lymph node.
(C) Quantitative RT-PCR of Pla2g2d mRNA in vWAT and sWAT of 12-week-old ob/ob mice and age-matched control (wild type [WT]) C57BL/6 mice (n = 4).
(D–F) Quantitative RT-PCR of Pla2g2d mRNA in adipocytes and SVF (n = 3) (D), in Sca1+CD11bCD45 (preadipocyte-rich) and Sca1CD11b+CD45+ (he-
matopoietic cell-rich) fractions sorted from SVF by fluorescence-activated cell sorting (FACS) (n = 3) (E), and in CD11chiCD206lo M1 macrophages and
CD11cloCD206hi M2 macrophages sorted from F4/80-gated SVF by FACS (n = 3) (F) from vWAT of LFD- or HFD-fed mice. Representative FACS profiles for (E)
and (F) are shown in Figures S1C and S1D.
(G) Immunofluorescence microscopy of PLA2G2D, F4/80, and CD206 in vWAT of LFD-fed C57BL/6 mice. PLA2G2D was colocalized in F4/80+ or CD206+
macrophages (arrowheads) in Pla2g2d+/+ mice, whereas it was scarcely stained in Pla2g2d/ mice (the asterisk indicates non-specific staining).
(H) Quantitative RT-PCR of Pla2g2d mRNA in BMDMs cultured for 24 h in the absence (M0) or presence of IFN-g + LPS (M1) or IL-4 (M2) (n = 9).
(I) Expression of Pla2g2dmRNA in BMDMs cultured for 24 h in the presence (+) or absence () of 100 mMpalmitic acid, the expression without palmitic acid being
regarded as 1 (n = 4).
Data are compiled from two experiments (B and H) or from one representative experiment (A, C, E–G, and I). Mean ± SEM, *p < 0.05, **p < 0.01.
See also Figure S1.
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Pla2g2d+/+ mice. Moreover, HFD-fed, but not LFD-fed,
Pla2g2d/ mice had a higher steady-state blood glucose level
and displayed greater insulin resistance in an insulin tolerance
test (ITT) than did replicatePla2g2d+/+ mice (Figure 2G), although
glucose clearance demonstrated by a glucose tolerance test
(GTT) was similar between the genotypes (Figure S2C). In
agreement with the aggravated insulin intolerance (Figure 2G),insulin-stimulated Akt phosphorylation tended to be reduced in
vWAT of Pla2g2d/ mice relative to Pla2g2d+/+ mice (Fig-
ure S2D). Although two diet-induced sPLA2s, PLA2G5 and
PLA2G2E, exert their metabolic effects by hydrolyzing lipopro-
tein phospholipids (Sato et al., 2014), neither of the lipid profiles
in plasma lipoproteins (Figure S2E) nor the phospholipid levels in
low-density lipoprotein (LDL) and high-density lipoprotein (HDL)
(Figure S2F) were altered in Pla2g2d/ mice regardless of diet.Cell Reports 31, 107579, May 5, 2020 3
Figure 2. Increased Diet-Induced Obesity in Pla2g2d–/– Mice
(A) Gross appearance of Pla2g2d+/+ (WT) and Pla2g2d–/– (KO) mice fed an LFD or HFD for 20 weeks.
(B) Body weights of WT and KO mice placed on an LFD or HFD for the indicated periods.
(C) Computed tomography (CT) analysis of fat volumes in WT and KO mice fed an LFD or HFD for 20 weeks. Yellow and purple areas indicate sWAT and vWAT,
respectively (inset).
(D) Hematoxylin-eosin staining of vWAT of WT and KO mice fed an LFD or HFD for 26 weeks (scale bar, 100 mm).
(E and F) Plasma leptin (E) and insulin (F) levels in LFD- or HFD-fed WT and KO mice.
(G) ITT using LFD- or HFD-fed WT and KO mice after fasting for 6 h.
(H) Quantitative RT-PCR of various genes in vWAT of LFD- or HFD-fed WT and KO mice, with expression in LFD-fed WT mice, normalized against Rn18s, being
regarded as 1 (n = 7).
(I and J) Flow cytometry of M1- andM2-typemacrophages in vWAT of HFD-fedWT and KOmice. Representative FACS profiles (I) and quantified values (n = 5) (J)
of M1- and M2-type macrophages are shown.
Data are compiled from one (I and J), two (C, E, F, and H), or three (B and G) experiments. Images in (A), (C), and (D) are representative of two experiments. In (B),
(C), and (E)–(G), sample sizes (n) are indicated in the figure. Mean ± SEM, *p < 0.05, **p < 0.01.
See also Figures S2 and S3.
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affected by Pla2g2d deficiency (Figure S2G). These results sug-
gest that the metabolic effects of PLA2G2D are not dependent
on lipoprotein phospholipid hydrolysis and not compensated
by other adipose tissue sPLA2s.
Quantitative RT-PCR of vWAT revealed that, although the
expression levels of adipogenic (Pparg and Fabp4), lipogenic
(Fasn and Scd1), or lipolytic (Pnpla2) genes were not affected
by Pla2g2d deficiency, those of pro-inflammatory M1 macro-
phagemarkers (Tnf, Il6, Il1b, andCcl2), but not anti-inflammatory4 Cell Reports 31, 107579, May 5, 2020M2 macrophage markers (Arg1 and Cd206), were consistently
elevated in HFD-fed Pla2g2d/ mice relative to Pla2g2d+/+
mice (Figure 2H). Moreover, flow cytometry of F4/80-gated mac-
rophages in vWAT revealed an increased proportion of
CD11chiCD206loM1-likemacrophages and an unaltered propor-
tion of CD11cloCD206hi M2-like macrophages in HFD-fed
Pla2g2d/ mice relative to Pla2g2d+/+ mice (Figures 2I and
2J), suggesting an increased M1/M2 ratio in the absence of
PLA2G2D. To assess whether these alterations already occurred
at an earlier period of diet-induced obesity, we examined the
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expression level of Pla2g2d in vWAT of HFD-fed mice still re-
mained high (Figure S3A) and Pla2g2d/ mice began to gain
more body weight than did Pla2g2d+/+ mice (Figure 2B). Trends
toward an increased proportion of CD11chiCD206lo M1-like
macrophages (Figures S3B and S3C) and an increased expres-
sion of Il1b (Figure S3D) were already evident in vWAT of
Pla2g2d/ mice after HFD feeding for 6 weeks, although the
M1/M2 ratio of WAT macrophages prior to HFD feeding was
similar between the genotypes (Figures S3B and S3C). Addition-
ally, the expression of pro-inflammatory genes (such as Ifng) in
regional lymph nodes, where PLA2G2D was highly expressed
(Figure 1A), was significantly greater in Pla2g2d/ mice than
in Pla2g2d+/+ mice after HFD feeding for 6 weeks (Figure S3E),
suggesting that the absence of PLA2G2D exacerbates HFD-
induced inflammation in the lymph nodes as well. In agreement
with these in vivo observations, when BMDMs were polarized
into M1- or M2-type macrophages ex vivo, expression of the
M1 marker Tnf was higher in Pla2g2d/ cells than in Pla2g2d+/+
cells, whereas that of the M2markerCd206was similar between
the genotypes (Figure S3F).
In contrast to the notable alterations in vWAT and lymph no-
des, HFD-induced hepatic steatosis in terms of liver histology
(Figure S3G), plasma level of alanine aminotransferase (ALT; a
marker of liver damage) (Figure S3H), and hepatic expression
of genes involved in lipid metabolism and inflammation
(Figure S3I) did not differ significantly between the genotypes,
probably because Pla2g2d expression in the liver was very low
(Figure 1A). Collectively, global ablation of Pla2g2d exacerbates
diet-induced obesity, insulin resistance, and adipose tissue
inflammation.
Macrophage-Specific Pla2g2d Ablation Recapitulates
the Metabolic Phenotypes
To address whether PLA2G2D expressed in M2-like macro-
phages could indeed participate in metabolic regulation, we
crossed Pla2g2dfl/fl mice with Lys2-Cre transgenic mice, which
have frequently been used for conditional deletion of a target
gene in the myeloid cell lineage, particularly in monocytes and
macrophages (Figure S4A). Conditional deletion of Pla2g2d
was verified by PCR genotyping (Figure S4B) and by quantitative
RT-PCR, in which Pla2g2d expression was largely even if not
solely abrogated in vWAT and sWAT, as well as in IL-4-treated,
M2-polarized BMDMs, prepared from Pla2g2dfl/flLys2-Cre
mice (Figure S4C). Because Pla2g2d expression is enriched in
macrophages and dendritic cells (Miki et al., 2013, 2016) and
very low in Ly6G1hiCD11b+ granulocytes (Figures S4D and
S4E), we reasoned that the phenotypes observed in Pla2g2dfl/
flLys2-Cre mice could be attributed largely to the lack of
PLA2G2D in the monocyte/macrophage lineage.
When fed an HFD, Pla2g2dfl/flLys2-Cre mice appeared more
obese (Figure 3A), displayed greater weight gain (Figure 3B),
and accumulated more visceral, subcutaneous, and total fats
(Figure 3C) than did control Pla2g2dfl/fl mice. Histologically,
vWAT of HFD-fed Pla2g2dfl/flLys2-Cre mice had larger adipo-
cytes with more crown-like structures (an indicator of macro-
phage infiltration) than that of replicate Pla2g2dfl/fl mice
(Figure 3D). Plasma leptin and insulin levels were higher (Figures3E and 3F) and insulin sensitivity as assessed by ITT was lower
(Figure 3G) in HFD-fed Pla2g2dfl/flLys2-Cre mice than in
Pla2g2dfl/fl mice, although glucose clearance as assessed by
GTT was similar in both genotypes (Figure S4F). Expression
levels of M1macrophage markers were elevated, whereas those
of M2 macrophage markers were unchanged or decreased, in
vWAT of HFD-fed Pla2g2dfl/flLys2-Cre mice relative to
Pla2g2dfl/fl mice (Figure 3H). There was no alteration of adipo-
genic, lipogenic, or lipolytic genes in vWAT of Pla2g2dfl/flLys2-
Cre mice (Figure 3H). Thus, the phenotypes resulting from
macrophage-specific Pla2g2d ablation largely recapitulate
those resulting from its global deficiency.
Impaired Adipocyte Browning and Adaptive
Thermogenesis in Pla2g2d/ Mice
Besides themetaboliccomplicationsdescribedabove,wenoticed
that Pla2g2d/ mice had significantly lower O2 and CO2 con-
sumption than did Pla2g2d+/+ mice under HFD and even normal
LFD conditions (Figures 4A and S5A). A steady-state reduction
of O2 consumption was also evident in Pla2g2d
fl/flLys2-Cre mice
relative to Pla2g2dfl/fl mice (Figure 4B). These results indicate
that energy expenditure under normal housing conditions was
reduced by the absence of PLA2G2D in macrophages, an event
that had not been observed in other sPLA2-knockout (KO) strains
(Sato et al., 2014). However, neither respiratory quotient (Fig-
ure S5B) nor locomotion (Figure S5C) was affected by global or
macrophage-specific Pla2g2d deletion. Notably, the expression
level of Ucp1, a key marker of non-shivering thermogenesis that
uncouples oxidative phosphorylation from energy production to
heat generation (Kozak, 2010), as well as several mitochondrial
thermogenic markers such as Cidea and Cox8b, tended to be
lower in vWAT of Pla2g2d/ or Pla2g2dfl/flLys2-Cre mice than in
that of respective control mice under normal housing conditions
(FigureS5D).We therefore speculated thatPla2g2d/micemight
have some alterations in the process of thermogenesis, thus
affecting energy expenditure.
b3-adrenergic signaling in response to cold stimulation upre-
gulates the expression of thermogenic genes in WAT, a process
known as ‘‘browning’’ (or ‘‘beiging’’) (Cao et al., 2011; Neder-
gaard and Cannon, 2014). Animals with impairment of beige
adipocyte function are vulnerable to metabolic challenges (Co-
hen et al., 2014; Jun et al., 2018). We therefore examined
whether cold-induced adipocyte browning would be perturbed
by Pla2g2d deficiency by placing Pla2g2d/ and Pla2g2d+/+
mice in a thermoneutral environment at 30C for 2 days and
then transferring them to a cold environment at 4C for up to
5 days. After this temperature shift, adipocytes in vWAT and
sWAT ofPla2g2d+/+ mice became smaller andmoremultilocular,
expressing higher levels of immunoreactive UCP1 protein (Fig-
ure 4C), a characteristic feature of adipocyte browning. Strik-
ingly, these cold-induced processes were markedly perturbed
in Pla2g2d/ mice (Figure 4C). Consistently, cold exposure re-
sulted in robust upregulation of Ucp1 and other mitochondrial
thermogenic markers in vWAT and even more in sWAT of
Pla2g2d+/+ mice, whereas Pla2g2d deficiency substantially
attenuated these cold-induced responses (Figure 4D). More-
over, after administration of CL316,243, a b3-adrenergic recep-
tor agonist, there was marked upregulation of Ucp1 and otherCell Reports 31, 107579, May 5, 2020 5
Figure 3. Increased Diet-Induced Obesity in Macrophage-Specific Pla2g2d-Null Mice
(A) Gross appearance of Pla2g2dfl/fl (control) and macrophage-specific Pla2g2d-deficient (Pla2g2dfl/flLys2-Cre; M-KO) mice fed an LFD or HFD for 20 weeks.
(B) Body weights of control and M-KO mice placed on an LFD or HFD for the indicated periods.
(C) CT analysis of fat volumes in control and M-KO mice fed an LFD or HFD for 26 weeks. Yellow and purple areas indicate sWAT and vWAT, respectively (inset).
(D) Hematoxylin-eosin staining of vWAT of control and M-KO mice fed an HFD for 26 weeks (scale bar, 100 mm).
(E and F) Plasma levels of leptin (E) and insulin (F) in LFD- or HFD-fed control and M-KO mice.
(G) ITT using LFD- or HFD-fed control and M-KO mice after fasting for 6 h.
(H) Quantitative RT-PCR of various genes in vWAT of HFD-fed control and M-KO mice, with the expression in control mice, normalized with Rn18s, being re-
garded as 1.
Data are compiled from two (E–G) or three (B and C) experiments. Images in (A), (C), and (D) are representative of two or three experiments. Sample sizes (n) are
indicated in the figure. Mean ± SEM, *p < 0.05, **p < 0.01.
See also Figure S4.
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Pla2g2d+/+ mice, whereas these responses were again impaired
in Pla2g2d/ mice (Figure 4E). Likewise, cold- or CL316,243-
induced upregulation of Ucp1 was substantially mitigated in
sWAT of Pla2g2dfl/flLys2-Cre mice (Figures S5E and S5F).
CL316,243 did not affect Pla2g2d expression in either vWAT or
sWAT (Figure S5G). In contrast, expression levels of various
thermogenic markers in interscapular BAT under normal
(23C), thermoneutral (30C), and cold (4C) conditions were
barely affected by Pla2g2d deletion (Figure S5H), likely because
of low Pla2g2d expression in BAT (Figure 1A).6 Cell Reports 31, 107579, May 5, 2020Reflecting the impaired adipocyte browning and thermogene-
sis resulting from Pla2g2d ablation, the cold-induced decrease
of rectal temperature was significantly greater in Pla2g2d/
mice than in Pla2g2d+/+ mice (Figure 4F). Moreover, cold-
induced expression of fibroblast growth factor 21 (FGF21), an
endocrine hormone that plays an intermediate role in adipocyte
browning (Fisher et al., 2012; Huang et al., 2017; Lee et al., 2014),
was lower in the plasma (Figure 4G) and in vWAT and sWAT (Fig-
ure 4H) of Pla2g2d/mice than in Pla2g2d+/+ mice. Collectively,
these results suggest that PLA2G2D promotes cold-induced
adipocyte browning and adaptive thermogenesis, which could
Figure 4. Decreased Adipocyte Browning and Thermogenesis Resulting from Pla2g2d Deficiency
(A and B) Oxygen consumption in Pla2g2d+/+ (WT) and Pla2g2d–/– (KO) mice fed an LFD (n = 4) or HFD (n = 7) for 26 weeks (A) or that of Pla2g2dfl/fl (control) and
Pla2g2dfl/flLys2-Cre (M-KO) mice maintained on an LFD (n = 6) (B) at 23C.
(C) Immunostaining of UCP1 in vWAT and sWAT of WT and KO mice placed at 30C for 2 days or at 4C for an additional 5 days (scale bar, 100 mm).
(D and E) Quantitative RT-PCR of thermogenesis-related genes in vWAT and sWAT ofWT and KOmice placed at 30C for 2 days or at 4C for an additional 5 days
(D) or after treatment with CL316,243 (1 mg/kg body weight) or saline for 3 days at 23C (E), with basal expression of each marker in WT mice at 30C (D) or with
saline treatment (E) being regarded as 1. Expression levels of several genes are magnified in the inset of (D).
(F) Rectal temperature of WT and KO mice placed at 30C for 2 days or at 4C for an additional 1 day (n = 13).
(G and H) FGF21 levels in plasma (n = 12) (G) and its mRNA expression in vWAT and sWAT (n = 9) (H) of WT and KOmice placed at 30C for 2 days or at 4C for an
additional 5 days.
In (D), (E), and (H), the expression levels of individual genes were normalized withGapdh. Data are compiled from two (A, B, D, and E) or three (F–H) experiments.
Images in (C) are representative of two experiments. In (D) and (E), sample sizes (n) are indicated in the figure. Mean ± SEM, *p < 0.05, **p < 0.01.
See also Figure S5.
Article
ll
OPEN ACCESSaccount, at least in part, for the exacerbated diet-induced
obesity in Pla2g2d/ mice. However, expression of neither
Prdm16, a key transcription factor for beige adipocyte develop-
ment (Cohen et al., 2014; Harms et al., 2014), nor type 2 cyto-
kines (Il4, Il5, Il13, and Il33), which facilitate adipocyte browning
(Lee et al., 2015; Uhm and Saltiel, 2015), in vWAT and sWAT was
significantly affected by Pla2g2d ablation (Figures 4D, 4E, and
S5I). Thus, during the process of WAT browning, PLA2G2D
might participate in a step prior to FGF21 induction and beyond
the core program for differentiation of beige adipocytes from
committed progenitors or for propagation of type 2 immunity.PLA2G2D Mobilizes PUFAs in WAT
Given that PLA2G2D is a phospholipase, we examined the pro-
file of PLA2-driven fatty acids and their metabolites in WAT by
electrospray ionization mass spectrometry (ESI-MS/MS). Under
steady-state LFD conditions, whenPla2g2d expressionwas high
(Figure 1A), the WAT levels of free PUFAs including AA (C20:4),
EPA (C20:5), and DHA (C22:6), but not palmitic acid (C16:0),
stearic acid (C18:0), oleic acid (OA; C18:1), and linoleic acid
(LA; C18:2), were significantly lower in Pla2g2d/ mice than in
Pla2g2d+/+ mice (Figures 5A and 5B). Moreover, at an earlier
time point of HFD feeding (6 weeks), when Pla2g2d expressionCell Reports 31, 107579, May 5, 2020 7
Figure 5. PLA2G2D Mobilizes PUFAs in WAT
(A and B) Lipidomics analyses of fatty acids inWAT of Pla2g2d+/+ (WT) and Pla2g2d–/– (KO) mice placed on an LFD or HFD for 26 weeks (n = 10). Relative levels of
fatty acids inWAT of LFD-fedmice, with values inWTmice being regarded as 1, are shown in (A), and quantified values (ng/mg tissue) of PUFAs under LFD or HFD
conditions are shown in (B).
(C) Expression of inflammatory M1 markers in BMDMs after culture for 24 h with 100 mM palmitate in the presence or absence of 20 mM PUFAs, 10 mM 9- or 13-
HODE, 50 mM GSK137647 (GPR120 agonist), or 10 mM pioglitazone (PPARg agonist) (n = 3).
(D and E) Quantitative RT-PCR of Ucp1 in ex-vivo-differentiated primary adipocytes after treatment for 24 h with various PUFAs (D) or with u3 PUFAs in the
presence or absence of the GPR120 antagonist AH7614 (E), with expression in the absence of PUFAs being regarded as 1 (n = 4).
(F) Quantitative RT-PCR of Ucp1 in WAT explants obtained from WT and KO mice. The explants were cultured for 6 h with 1 mM CL316,243 in the presence or
absence of 100 mM EPA (n = 10).
(G) Body weights of WT and KO mice placed on a control or u3 PUFA-rich diet (adjusted to fat calorie 45%) for the indicated periods. *p < 0.05, control diet WT
versus control diet KO; #p < 0.05, control diet WT versus u3-rich diet WT; and $p < 0.05, control diet WT versus u3-rich diet KO by ANOVA Dunnett’s test.
(H) Quantitative RT-PCR of Ucp1 in sWAT of WT and KOmice fed a control or u3 PUFA-rich diet for 10 weeks. Mice were treated with CL316,243 (1 mg/kg body
weight) or saline for 3 days.
(I) Quantitative RT-PCR of Tnf in vWAT of WT and KO mice fed a control or u3 PUFA-rich diet for 10 weeks.
In (C)–(F), (H), and (I), expression levels of individual genes are normalized with Gapdh. Data are compiled from (A), (B), and (F)–(I) or representative of two ex-
periments (C–E). In (B) and (G)–(I), sample sizes (n) are indicated in the figure. Mean ± SEM, *p < 0.05, **p < 0.01.
See also Figure S6.
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lesser extent AA, were lower in the WAT (Figure S6A) and lymph
nodes (Figure S6B) of Pla2g2d/ mice than in those of
Pla2g2d+/+ mice. This fatty acid selectivity agrees with the enzy-
matic activity of PLA2G2D, which preferentially releases PUFAs,
u3 in particular (Miki et al., 2013). After HFD feeding for 20weeks,8 Cell Reports 31, 107579, May 5, 2020when Pla2g2d expression was downregulated (Figure 1A), the
decreased levels of PUFAs (EPA and DHA in particular, primarily
due to their low content in HFD) were indistinguishable between
the genotypes (Figure 5B). These results suggest that PLA2G2D
constitutively supplies nearly half of the free PUFAs (preferen-
tially u3 EPA and DHA) in WAT under normal to an early stage
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induced obesity. Phospholipid levels in WAT were barely altered
by PLA2G2D deficiency, most likely because the local changes
of phospholipids by sPLA2s in a subset of cells were masked
by high background levels of bulk phospholipids in the whole
tissue.
However, the WAT levels of most u3/u6 PUFA-derived lipid
mediators detected so far did not differ significantly between
Pla2g2d+/+ and Pla2g2d/ mice (Figure S6C), suggesting that
PLA2G2D-driven PUFAs in WAT are hardly converted to lipid
mediators, the latter being producedmainly from a PLA2G2D-in-
dependent PUFA pool. In comparison, the WAT levels of PUFAs
and their metabolites were not profoundly affected in mice lack-
ing PLA2G5, a diet-inducible sPLA2 that preferentially releases
OA and LA from LDL phospholipids (Sato et al., 2014), or
PLA2G4A (also known as cPLA2a) (Figures S6D and S6E), which
is thought to be coupled with canonical AA metabolism in many
tissues (Shimizu, 2009). Thus, generation of PUFA-derived lipid
mediators in WAT may be mostly regulated by other phospholi-
pases or lipases.
PUFAs by themselves have beneficial actions on metabolism,
inflammation, and thermogenesis through several mechanisms
involving GPR120, PPARg, or others (Fan et al., 2019). Indeed,
M1 polarization of BMDMs by palmitic acid, as monitored by in-
duction of several M1 markers, was partially (for Nos2 and Il1b)
or almost entirely (for Il6) dampened by PUFAs including LA,
AA, EPA, and DHA (Figure 5C). 9- and 13-hydroxyoctadecaenoic
acids (HODEs), the most abundant lipid mediators detected in
WAT thus far (Figure S6C), were ineffective (Figure 5C). The in-
duction of Nos2 was suppressed partially by either
GSK137647 (GPR120 agonist) or pioglitazone (PPARg agonist),
that of Il1b was reduced partially by GSK137647 but not by pio-
glitazone, and that of Il6 was almost totally insensitive to both
agents (Figure 5C). Thus, PUFAs attenuate the expression of
these pro-inflammatory M1 macrophage markers through multi-
ple mechanisms. Furthermore, consistent with a recent study
(Quesada-López et al., 2016), EPA andDHA aswell as a-linolenic
acid (ALA; C18:3 u3), but not u6 PUFAs (LA and AA), increased
the expression of Ucp1, which was largely blunted by the
GPR120 antagonist AH7614, in sWAT-derived, ex-vivo-differen-
tiated primary adipocytes (Figures 5D and 5E), supporting the
notion that u3 PUFAs can promote adipocyte browning through
acting on GPR120.
u3 PUFA Supplementation Restores Metabolic
Alterations in Pla2g2d/ Mice
Wenext examinedwhether themetabolic alterations observed in
Pla2g2d/ mice could be restored by supplementation with u3
PUFAs. To this end, sWAT was isolated from Pla2g2d+/+ and
Pla2g2d/mice and stimulated with CL316,243 in the presence
or absence of EPA in an ex vivo culture. Consistent with the in vivo
results (Figure 4E), the expression of Ucp1 was significantly
lower in the sWAT explant of Pla2g2d/ mice than in that of
Pla2g2d+/+ mice (Figure 5F). Addition of EPA to the culture
increasedUcp1 expression in Pla2g2d/ sWAT to a level similar
to that in Pla2g2d+/+ sWAT (Figure 5F), indicating that the
decreased adipocyte browning in Pla2g2d/ mice could be
restored by exogenous EPA ex vivo. To further address this issuein vivo, Pla2g2d+/+ and Pla2g2d/ mice were fed an u3 PUFA-
rich diet in comparison with a lard-rich control diet, with 45% fat
calorie in both diets. Consistent with Figure 2B, Pla2g2d/mice
gainedmoreweight than didPla2g2d+/+mice under lard-rich diet
conditions (Figure 5G). Strikingly, following u3 PUFA-rich diet
feeding, the weight gain tended to be milder in both Pla2g2d+/+
and Pla2g2d/mice, with no difference between the genotypes
at each time point (Figure 5G). When these mice were treated
with CL316,243 at 10 weeks, Ucp1 expression in sWAT was
lower in Pla2g2d/ mice than in Pla2g2d+/+ mice on the lard-
rich control diet, whereas feeding of the u3 PUFA-rich diet
increased Ucp1 expression in sWAT of both Pla2g2d+/+ and
Pla2g2d/ mice to a similar level (Figure 5H), as in the case of
the ex vivo results (Figure 5F). Moreover, although vWAT expres-
sion of Tnf tended to be greater in Pla2g2d/ mice than in
Pla2g2d+/+ mice after feeding of the lard-rich diet, this event
was not evident in these mice after feeding of the u3 PUFA-
rich diet (Figure 5I). These results collectively suggest that the
metabolic alterations in Pla2g2d/ mice, including reduced
adipocyte browning, increased diet-induced obesity, and
increased WAT inflammation, are almost fully rescued by u3
PUFA supplementation. Thus, we conclude that PLA2G2D
constitutively supplies a pool of u3 PUFAs in WAT, thereby
contributing to maintenance of metabolic health by promoting
adipocyte browning and by ameliorating chronic inflammation.
DISCUSSION
It has been well recognized that PUFAs, particularly u3 PUFAs,
have beneficial effects on systemic metabolism (Fan et al.,
2019). Dietary treatment of experimental animals with u3 PUFAs
or fish oil (Itariu et al., 2012; Neuhofer et al., 2013) or transgenic
overexpression of fat-1, which encodes an u3 PUFA-producing
desaturase inCaenorhabditis elegans, inmice (White et al., 2010)
ameliorates obesity-associated inflammation and insulin resis-
tance. u3 PUFAs can also promote BAT recruitment and WAT
browning in association with enhanced sympathetic neuronal
tone, which eventually prevents obesity-related metabolic com-
plications (Flachs et al., 2011; Kim et al., 2015, 2016; Laiglesia
et al., 2016; Sadurskis et al., 1995; Villarroya et al., 2014; Zhao
and Chen, 2014). Mechanistically, u3 (and in some cases u6)
PUFAs exert their advantageous metabolic effects through their
conversion to anti-inflammatory or pro-resolving lipid mediators
(Clària et al., 2012; González-Périz et al., 2009; Neuhofer et al.,
2013; Titos et al., 2011), their direct action on PUFA-sensing
receptors (e.g., GPR120 and PPARs) (Cipolletta et al., 2012; Ha-
maguchi and Sakaguchi, 2012; Oishi et al., 2017), or attenuation
of endoplasmic reticulum (ER) stress by increasing membrane
fluidity after being incorporated into membrane phospholipids
(Ariyama et al., 2010), among other mechanisms. Indeed, ge-
netic deletion ormutation of GPR120, anu3 PUFA receptor (Ichi-
mura et al., 2012; Oh et al., 2010, 2014; Quesada-López et al.,
2016; Yan et al., 2013), or LPCAT3, a lysophospholipid acyltrans-
ferase that preferentially incorporates PUFAs into membrane
phospholipids (Rong et al., 2017; Wang et al., 2016), leads to
metabolic perturbations.
Because a large proportion of PUFAs are stored in membrane
phospholipids and spatiotemporally released by PLA2 enzymes,Cell Reports 31, 107579, May 5, 2020 9
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PLA2(s) that supplies PUFAs in metabolically active tissues for
metabolic regulation. In this study, we have provided evidence
that PLA2G2D, a member of the sPLA2 family, is responsible
for this process. Recent studies using mice deficient in various
sPLA2 isoforms, which show different substrate specificities
and tissue distributions, have revealed that these enzymes
participate in various biological events, including exacerbation
or prevention of inflammatory, metabolic, and other diseases,
by driving distinct lipid pathways in given tissue microenviron-
ments (Boudreau et al., 2014; Labonté et al., 2010; Miki et al.,
2013; Murase et al., 2016; Sato et al., 2014; Taketomi et al.,
2013; Yamamoto et al., 2015). Of these, PLA2G2D is expressed
abundantly in lymphatic dendritic cells and macrophages, putt-
ing a brake on harmful immune responses in Th1-driven contact
dermatitis and Th17-driven psoriasis by constitutively supplying
u3 PUFA-derived pro-resolving lipid mediators (Miki et al., 2013,
2016). Here we have shown that PLA2G2D is preferentially and
constitutively expressed in M2-like macrophages within WAT
and exhibits a reciprocal correlation with obesity and insulin
resistance. This expression profile of PLA2G2D contrasts with
that of PLA2G5 and PLA2G2E, which are induced in hypertro-
phic adipocytes during obesity (Sato et al., 2014). Downregula-
tion of Pla2g2d during inflammation, such as in LPS-stimulated
macrophages and in antigen-captured major histocompatibility
complex (MHC) class IIhi dendritic cells, has also been demon-
strated in previous studies (Miki et al., 2013, 2016; von Allmen
et al., 2009). Considering that obesity is accompanied by chronic
inflammation in WAT, with a myriad of pro-inflammatory factors
in adipose tissue microenvironments, it is plausible that Pla2g2d
expression declines with obesity in response to one or more of
these pro-inflammatory factors. Indeed, our data show that pal-
mitic acid, a pro-inflammatory SFA that is abundantly present in
adipose tissue during obesity, reduces Pla2g2d expression in
macrophages.
Importantly, both global and macrophage-specific deletions
of PLA2G2D lead to exacerbation of diet-induced obesity, insulin
resistance, and adipose tissue inflammation, a finding that sup-
ports the anti-inflammatory role of this enzyme as a ‘‘resolving
sPLA2’’ (Miki et al., 2013). Because the absence of PLA2G2D
does not profoundly affect the liver and BAT, where the expres-
sion of this enzyme is very low, it is likely that PLA2G2D
expressed locally in WAT plays a leading role in metabolic regu-
lation. However, considering an increased expression of Th1 cy-
tokines and a marked reduction of anti-inflammatory u3 PUFAs
in regional lymph nodes of Pla2g2d/ mice at an early stage of
diet-induced obesity, it is possible that an anti-inflammatory
state in lymph organs mediated by PLA2G2D-driven u3 PUFA
metabolites (Miki et al., 2013) might also contribute, at least
partly, to the anti-obesity function of this enzyme. Indeed, lymph
node cells in Pla2g2d/ mice are prone to be hyperactivated in
the contexts of Th1-driven contact hypersensitivity and Th17-
driven psoriasis (Miki et al., 2013, 2016), suggesting that Pla2g2d
deficiency promotesM1 skewing ofmacrophages at the onset of
disease.
Understanding the molecular mechanisms and signaling net-
works that induce beige adipocytes is of fundamental impor-
tance for research aimed at obesity prevention (Harms and10 Cell Reports 31, 107579, May 5, 2020Seale, 2013; Kajimura et al., 2015). Reductions in beige fat activ-
ity predispose animals to the harmful metabolic effects of an
HFD (Cohen et al., 2014). Beyond a recent study using trans-
genic mice overexpressing PLA2G2A (sPLA2-IIA), in which
WAT was shown to be more prone to adipocyte browning with
increased expression of thermogenic markers (Kuefner et al.,
2019), the present study highlights that an endogenous sPLA2,
i.e., PLA2G2D, does regulate adipocyte browning and adaptive
thermogenesis. This function of PLA2G2D is consistent with its
more abundant expression in sWAT, the primary site for cold-
induced adipocyte browning, than in vWAT. It has been well
documented that various types of immune cells residing in
WAT closely interact with adipocytes and regulate metabolic ho-
meostasis in positive and negative ways (Brestoff and Artis,
2015). In particular, type 2 immunity involving type 2 innate
lymphoid cells (ILC2s), eosinophils, andM2macrophages exerts
accelerating effects on adipocyte browning (Nguyen et al., 2011;
Qiu et al., 2014; Rao et al., 2014; Wu et al., 2011). Although M2
macrophages were initially proposed to promote adipocyte
browning by synthesizing norepinephrine (Nguyen et al., 2011),
this idea has recently been challenged by others (Fischer et al.,
2017; Jiang et al., 2017). Rather, a population of adipose tissue
macrophages influences b3-adrenergic tone by taking up and
degrading, rather than synthesizing, norepinephrine (Camell
et al., 2017; Pirzgalska et al., 2017) or by inhibiting sympathetic
innervation over time (Wolf et al., 2017). Regardless of the
norepinephrine paradox, other studies have recently shown
that some natural ligands for PPARg, a nuclear receptor that
binds to u3 PUFAs (Lee et al., 2013, 2016), and acetylcholine,
which acts on the nicotinic receptor CHRNA2 (Jun et al., 2018),
serve as M2 macrophage-derived paracrine factors that facili-
tate adipocyte browning. Our present study appears to fit with
the former notion, underscoring PLA2G2D as a previously unrec-
ognized factor that links M2-like macrophages to adipocyte
browning through the supply of PUFAs.
Pla2g2d deficiency leads to significant reduction of PUFAs,
particularly u3 EPA and DHA, without alterations to their
oxygenated metabolites in WAT, suggesting that the metabolic
regulation by PLA2G2D relies largely, even if not solely, on the
supply of a pool of PUFAs themselves. Among a number of
local factors that can affect adipocyte browning (Reitman,
2017; Villarroya et al., 2018), FGF21 produced by adipocytes
in response to b3-adrenergic signals integrates type 2 immunity
and adipocyte browning (Huang et al., 2017). u3 PUFAs, by
acting on the PUFA receptor GPR120 (Quesada-López et al.,
2016) or PPARg (Qiang et al., 2012; Vernochet et al., 2009;
Wang et al., 2016), augment FGF21 production by adipocytes
and thereby facilitate adipocyte browning and thermogenesis.
Consistently, we have shown here that u3 (rather than u6) PU-
FAs are capable of upregulating Ucp1 expression in sWAT-
derived adipocytes in a manner dependent upon GPR120.
Indeed, the exacerbated metabolic phenotypes observed in
Pla2g2d/ mice are similar in many aspects to those observed
in mice lacking GPR120 (Ffar4/), which also display
increased diet-induced obesity, insulin resistance, and adipose
tissue inflammation, in association with reduced energy expen-
diture, adipocyte browning, thermogenesis, and FGF21 expres-
sion (Ichimura et al., 2012; Oh et al., 2010, 2014; Quesada-
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action between M2-type macrophages and beige adipocytes
through the PLA2G2D-u3 PUFA-GPR120 axis may coordinate
organismal fitness after environmental challenges to cold,
whereas perturbation of this regulatory pathway hampers
metabolic homeostasis upon nutritional overload. From this
standpoint, the M1-skewed inflammatory profile in WAT of
HFD-fed Pla2g2d/ mice might be a consequence, rather
than a cause, of the increased obesity resulting from reduced
adipocyte browning and thereby energy expenditure, although
the possibility that the decreased anti-inflammatory u3 PUFA
tone might additionally affect the property of macrophages
cannot be fully ruled out. In support of the latter idea, macro-
phages in lymphoid organs are skewed into M1-like macro-
phages in Pla2g2d/ mice even under normal conditions,
most likely due to the reduction of u3 PUFAs (Miki et al., 2016).
Because sPLA2 hydrolyzes phospholipids in extracellular mi-
croparticles or exosomes (Boudreau et al., 2014) and adipose
tissue is a rich source of such extracellular vesicles (Crewe
et al., 2018; Thomou et al., 2017), it is tempting to speculate
that PLA2G2D secreted from M2-type macrophages within a
WAT niche may hydrolyze phospholipids in adipocyte-derived
extracellular vesicles to release a pool of free PUFAs that are
not readily accessible to downstream enzymes for lipid mediator
biosynthesis. Alternatively, because M2-type macrophages can
support adipocyte browning through elimination of cell remnants
in association with PPARg ligand synthesis during tissue remod-
eling (Lee et al., 2016), PLA2G2D may release PUFAs from the
remnant membranes. Such a PUFA pool spatiotemporally
mobilized by PLA2G2D in WAT may in turn promote adipocyte
browning through GPR120- and/or PPARg-dependent pro-
cesses or through alternative mechanisms such as attenuation
of ER stress (Okla et al., 2015). It is also possible that certain
PUFA-derived metabolites that were not evaluated in this study
might also be involved in PLA2G2D action.
It is noteworthy that >50% of free PUFAs still remained in
Pla2g2d/ WAT, suggesting the existence of a different route(s)
for the supply of PUFAs that could be coupled with their conver-
sion to lipid mediators. Our results using Pla2g4a/ mice
suggest that the contribution of PLA2G4A (cPLA2a), a canonical
regulator of AA metabolism (Shimizu, 2009), to eicosanoid syn-
thesis is negligible in WAT, arguing for the role of other PLA2s.
It has been reported that PLA2G16 (adipose-specific PLA) is
linked to PGE2 generation in WAT (Jaworski et al., 2009),
although subsequent studies have claimed that this enzyme
has more robust PLA1 than PLA2 activity and might participate
in lipid metabolism other than eicosanoid generation (Pang
et al., 2012; Uyama et al., 2012). Alternatively, the PUFA-derived
mediators in WAT may be supplied from neutral lipids through
the lipolytic pathway involving adipose triglyceride lipase
(ATGL; also known as PNPLA2 or iPLA2z), hormone-sensitive
lipase, and monoacylglycerol lipase. Indeed, pharmacological
or genetic inactivation of these lipases alleviates the generation
of AA metabolites in several situations (Dichlberger et al., 2014;
Nomura et al., 2011; Ogasawara et al., 2016), and EPA-derived
12-hydroxyeicosapentaenoic acid (12-HEPE), which is pro-
duced by the sequential action of ATGL and 12-lipoxygenase,
regulates BAT functions (Leiria et al., 2019).In conclusion, the present study has highlighted PLA2G2D as
a regulator of metabolic health. The PLA2G2D-u3 PUFA axis
facilitates energy expenditure through increased adipocyte
browning and thermogenesis, thereby protecting against diet-
induced obesity, adipose tissue inflammation, and insulin
resistance. Thus, when considered along with the results of our
previous study (Sato et al., 2014), it appears that three sPLA2s
(PLA2G2D, PLA2G2E, and PLA2G5) spatiotemporally expressed
in distinct cells within WAT exert different impacts on systemic
metabolism through mobilization of distinct lipid pathways (Fig-
ure 6). From the standpoint of PLA2 biology, PLA2G2D acts not
merely as a ‘‘resolving sPLA2’’ that sequesters inflammation
(Miki et al., 2013) but also as a ‘‘thermogenic sPLA2’’ that facili-
tates adaptive thermogenesis, a property that is not shared by
other sPLA2s or any other PLA2 subtypes reported so far.
Because PLA2G2D is also expressed in human macrophages
and its potential role in human bodyweight control has been sug-
gested from a study employing a SNP in the PLA2G2D gene
(Takabatake et al., 2005), it is likely that the enzyme may also
play similar roles in humans. Our results point to potential
prophylactic or therapeutic use of PLA2G2D itself or an agent
that could specifically stabilize or upregulate PLA2G2D to afford
protection against metabolic diseases.STAR+METHODS
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Figure 6. Schematic Diagram of Metabolic Regulation by sPLA2s in WAT
InWAT, PLA2G5 and PLA2G2E are induced in hypertrophic adipocytes during obesity, whereas PLA2G2D is constitutively expressed inM2-typemacrophages in
lean WAT. Obesity-induced PLA2G5 prevents metabolic disorders by hydrolyzing PC in low-density lipoprotein (LDL) to supply OA and LA, which attenuate
palmitate-induced M1 macrophage skewing, whereas PLA2G2E hydrolyzes minor lipoprotein phospholipids (PE and PS) and increases adiposity through an
unknownmechanism (Sato et al., 2014). PLA2G2D, which preferentially releasesu3 PUFAs possibly from phospholipids in extracellular vesicles (EVs), promotes
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Antibodies
Goat anti-rabbit IgG (H+L) superclonal
secondary antibody, Alexa Fluor 555
Thermo Fisher Scientific Cat# A27039; RRID: AB_2536100
Rat anti-mouse F4/80 (clone Cl:A3-1) Bio-Rad Cat# MCA497GA; RRID: AB_323806
Rat anti-mouse CD206 (clone MR5D3) Bio-Rad Cat# MCA2235XZ; RRID: AB_324449
Rabbit anti-sPLA2-IID polyclonal antibody Miki et al., 2013 N/A
Rabbit polyclonal anti-UCP1 Abcam Cat# ab10983; RRID: AB_2241462
Rabbit monoclonal anti-P-Akt (Ser473)
(clone D9E)
Cell Signaling Technology Cat# 4060; RRID: AB_2315049
Goat anti-rabbit IgG, Fc, HRP conjugate
antibody
Millipore Cat# AP156P; RRID: AB_91699
TruStain fcX (anti-mouse CD16/32) antibody Biolegend Cat# 101320; RRID: AB_1574975
APC anti-mouse/human CD11b (clone M1/70) Biolegend Cat# 101211; RRID: AB_312794
Anti-mouse CD11c PE (clone N418) Thermo Fisher Scientific Cat# 12-0114-81; RRID: AB_465551
FITC anti-mouse F4/80 (clone BM8) Biolegend Cat# 123107; RRID: AB_893500
Alexa Fluor 647 anti-mouse CD206 (MMR)
(clone C068C2)
Biolegend Cat# 141712; RRID: AB_10900420
CD45monoclonal antibody FITC (clone 30-F11) Thermo Fisher Scientific Cat# 11-0451-81; RRID: AB_465049
FITC anti-mouse F4/80 (clone BM8) Biolegend Cat# 123107; RRID: AB_893500
PE rat anti-mouse Ly-6A/E (Sca-1) (clone D7) BD PharMingen Cat# 553108
Alexa Fluor 647 rat anti-mouse CD45R (B220)
(clone RA3-6B2)
BD PharMingen Cat# 557683
PE rat anti-mouse Ly-6G and Ly-6C (Gr1)
(clone RB6-8C5)
BD PharMingen Cat# 553128
Alexa Fluor 488 anti-mouse CD3ε (clone
145-2C11)
Biolegend Cat# 100321, RRID: AB_389300
PE rat IgG2a, kappa isotype control antibody
(clone RTK2758)
Biolegend Cat# 400508; RRID: AB_326530
PE/Cy7 armenian hamster IgG isotype control
antibody (HTK888)
Biolegend Cat# 400907; RRID: AB_326593
PE rat IgG2b, kappa isotype control antibody
(clone RTK4530)
Biolegend Cat# 400508, RRID: AB_326530
Alexa Fluor 647 rat IgG2b, kappa isotype
control antibody (clone RTK4530)
Biolegend Cat# 400626; RRID: AB_389343
Chemicals, Peptides, and Recombinant Proteins
Trizol reagent Invitrogen Cat# 15596026
Insulin solution Sigma-Aldrich Cat# I0516
Humalog Eli Lilly Cat# VL-7510
DAPI (4’,6-Diamidino-2-phenylindole
dihydrochloride)
Thermo Fisher Scientific Cat# D1306
Collagenase D Roche Cat# 11088882001
Collagenase type II Worthington Cat# LS004176
Dispase II Thermo Fisher Scientific Cat# 17105041
Rosiglitazone Sigma-Aldrich Cat# R2408
CL316,243 Sigma-Aldrich Cat# C5976
LPS Sigma-Aldrich Cat# L2654
(Continued on next page)
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Recombinant murine IFN-g PreproTech Cat# 315-05
Leukoprol Kyowa Kirin Cat# 873399
Recombinant murine IL-4 PreproTech Cat# 214-14
Recombinant murine IL-13 PreproTech Cat# 210-13
Palmitic acid Sigma-Aldrich Cat# P0500
Linoleic acid Cayman Chemicals Cat# 60-33-3
Arachidonic acid Cayman Chemicals Cat# 506-32-1
a-Linolenic acid Cayman Chemicals Cat# 463-40-1
Eicosapentaenoic acid Cayman Chemicals Cat# 10417-94-4
Docosahexaenoic acid Cayman Chemicals Cat# 6217-54-5
9(S)-HODE Cayman Chemicals Cat# 73543-67-6
13(S)-HODE Cayman Chemicals Cat# 1176496-97-1
Eicosapentaenoic acid-d5 Cayman Chemicals Cat# 10005056
1-heptadecanoyl-2-hydroxy-sn-glycero-3-
phosphocholine (LysoPC17:0)
Avanti Polar Lipids Cat# 855676
GSK137647 Tocris Cat# 5257
AH7614 Tocris Cat# 5256
Pioglitazone Sigma-Aldrich Cat# E6910
cOmplete mini protease inhibitor cocktail
tablets
Roche Cat# 11836153001
PhosSTOP phosphatase inhibitor cocktail
tablets
Roche Cat# 4906837001
MEMa Wako Cat# 135-15175
DMEM/F-12, GlutaMAX supplement Thermo Fisher Scientific Cat# 10565042
Critical Commercial Assays
Mouse Insulin ELISA Kit Morinaga Cat# M1102
Mouse/Rat Leptin Quantikine ELISA Kit R&D Cat# MOB00
Mouse/Rat FGF-21 Quantikine ELISA Kit R&D Cat# MF2100
Transaminase CII-test Wako Kit Wako Cat# 431-30901
High Capacity cDNA Reverse Transcription Kit Thermo Fisher Scientific Cat# 4368814
TaqMan Gene Expression Master Mix Thermo Fisher Scientific Cat# 4369016
EnVision Detection System Dako Cat# K5007
Pierce BCA Protein Assay Kit Thermo Fisher Scientific Cat# 23227
ECL Prime western blotting detection reagent GE Healthcare Cat# RPN2232
RNeasy Lipid Tissue Mini Kit QIAGEN Cat# 74804
Experimental Models: Organisms/Strains
Mouse: Floxed (exon 2, 3) Pla2g2d mice
(Pla2g2df/f)
This paper See Figure S4A
Mouse: B6.129P2-Lyz2 tm1(cre)Ifo/J RIKEN RBRC02302
Mouse: B6.Cg-Lep ob/J The Jackson Laboratory Cat# 00632; RRID: IMSR_JAX:000632
Mouse: Pla2g4a–/– mice Uozumi et al., 1997 N/A
Oligonucleotides
Primer/probe list for TaqMan Gene Expression
Assay (see Table S1 for a full list)
This paper See Table S1
Software and Algorithms
FlowJo software v.10 TreeStar https://www.flowjo.com/
Excel statistical program file yStat 2008 Igaku Tosho Shuppan N/A
BZ-X Analyzer KEYENCE N/A
ImageJ NIH https://fiji.sc/
(Continued on next page)
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MultiQuant software v.3 AB SCIEX https://sciex.jp/products/software/
multiquant-software
Other
High Fat Diet 32 CLEA-Japan Cat# HFD32
D12451 (Control diet) Research Diet See Table S2
D10020201 (u3 PUFA-rich diet) Research Diet See Table S2
Medisafe mini Terumo Cat# GR-102
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OPEN ACCESSLEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Makoto
Murakami (makmurak@m.u-tokyo.ac.jp). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Global Pla2g2d–/– and Pla2g2dfl/fl mice were backcrossed onto a C57BL/6 genetic background (Japan SLC) for > 12 generations,
and genotyping was performed on genomic DNA from tail biopsies by PCR (Miki et al., 2013). For conditional deletion of Pla2g2d
in macrophages, Pla2g2dfl/fl mice were crossed with Lys2-Cre mice (Jackson Laboratory). Genotyping of conditional Pla2g2d–/–
mice were performed using combined sets of sense primers 50-agcacttgacacctgatgctgttccttctc-30 or 50-tagttggtgagcttc aggcta-
30 and an antisense primer 50-ggacagattacagaggaggtcatggcatttc-30 (Figure S4A). The PCR conditions were 95C for 10 s and
then 35 cycles of 95C for 0 s and 65C for 1 min on a Veriti Fast thermal cycler (Applied Biosystems), and the PCR products
were analyzed by 1.5% (w/v) agarose gel electrophoresis with ethidium bromide. Lepob/ob mice were obtained from Jackson Lab-
oratory. Pla2g4a/ mice were described previously (Uozumi et al., 1997). All mice were housed in climate-controlled (23C) path-
ogen-free facilities with a 12 h light-dark cycle, with free access to standard LFD (CE-2; CLEA Japan) and water. All procedures
involving animals were performed in accordance with protocols approved by the Institutional Animal Care and Use Committees of
the University of Tokyo and Tokyo Metropolitan Institute of Medical Science under the Japanese Guide for the Care and Use of
Laboratory Animals.
Culture of BMDMs
Mouse BM cells were cultured in MEMa medium (Wako) containing 10% (v/v) FBS, 100 U/ml penicillin and 100 mg/ml streptomycin
supplemented with 100 ng/ml M-CSF (Leukoprol; Kyowa Kirin) to obtain BMDMs. The M-CSF-driven BMDMs were cultured for 12 h
in serum-free medium (M0 macrophages) and then for 24 h in culture medium supplemented with 1 mg/ml LPS (Sigma-Aldrich) and
10 ng/ml IFN-g (Peprotech) to induce M1 macrophages or with 20 ng/ml IL-4 (Peprotech) to induce M2 macrophages (Kadl et al.,
2010). As required, following agents were added to the culture: 20 mM LA, AA, EPA or DHA, 10 mM 9(S)- or 13(S)-HODE (Cayman
Chemicals), 100 mM palmitic acid (Sigma-Aldrich), 10 mM pioglitazone (PPARg agonist) (Sigma-Aldrich), or 50 mM GSK137647
(GPR120 agonist) (Tocris).
Culture of primary adipocytes
Culture of primary adipocytes from sWAT was performed as described previously (Ohno et al., 2012). In brief, fat depots were di-
gested in PBS containing 1.5 U/ml collagenase D (Roche) and 2.4 U/ml dispase II (Thermo Fisher Scientific) supplemented with
10 mM CaCl2 at 37 C for 40-45 min. The primary cells were filtered through a 70-mm cell strainer and centrifuge at 500 g to collect
SVF cells, which were then rinsed and plated on collagen coated plates. Adipocyte differentiation was induced by treating confluent
cells in DMEM/F12 medium containing 10% FBS, 0.5 mM isobutylmethylxanthine, 125 nM indomethacin, 1 mM dexamethasone,
850 nM insulin, 1 mM rosiglitazone and 1 nM T3 (all from Sigma-Aldrich). Two days after induction, cells were switched to the main-
tenance medium containing 10% FBS, 850 nM insulin, 1 mM rosiglitazone and 1 nM T3. The differentiated cells were cultured for 24 h
in lipid-depletedmedium and then for 24 h in culturemedium supplemented with 100 mMPUFAs (CaymanChemicals) in the presence
or absence of 100 mM AH7614 (GPR120 antagonist) (Tocris).
Ex vivo culture of WAT explants
Mouse sWAT was cultured in 1 mL of DMEM/F-12 medium containing 10% FBS, penicillin/streptomycin, and 2 mM GlutaMAXTM
supplement (Thermo Fisher Scientific). After pretreatment with 100 mM EPA or vehicle for 2 h, the sWAT explants were cultured in





Total RNA was extracted from tissues using TRIzol reagent (Invitrogen). RNA was isolated from mouse tissues using the
RNeasy Lipid Tissue Mini kit (QIAGEN). First-strand cDNA synthesis was performed using a High Capacity cDNA Reverse Tran-
scriptase Kit (Applied Biosystems). PCR reactions were carried out using a TaqMan Gene Expression System (Applied Bio-
systems) on the ABI7300 and StepOnePlus Real Time PCR systems (Applied Biosystems). The probe/primer sets used are
listed in Table S1.
Experiments using special diets
In the experiments for diet-induced obesity, global or macrophage-specific Pla2g2d-deficient mice and littermate control mice (8-
wk-old, female) were placed on a HFD (High-fat diet 32; CLEA Japan) for up to 26 weeks, with thosemicemaintained on LFD (Rodent
diet CE-2; CLEA Japan) as a control. In the rescue experiments, Pla2g2d+/+ and Pla2g2d/ mice were fed an u3 PUFA-rich diet
(D10020201; Research Diet) or lard-rich control diet (D12451; Research Diet) for up to 10 weeks. The composition of the u3
PUFA-rich and control diets are shown in Table S2.
Adipocyte browning
For b3-adrenergic stimulation, 810-week-old female mice were treated intraperitoneally with the b3-adrenergic agonist CL316,243
(1mg/kg bodyweight, Sigma-Aldrich) once a day for 3 days. For cold stimulation,micewere placed at 30C for 2 days and then at 4C
for appropriate periods in a temperature-controlled chamber (HC-10, Shin Factory). Rectal temperature wasmeasured using an elec-
tronic thermometer (Physitemp Instruments). Expression of genes related to adipocyte browning and thermogenesis was evaluated
by quantitative RT-PCR.
Glucose and insulin tolerance tests
Mice were fasted for 16 and 6 hours before intraperitoneally injection of glucose (2 mg glucose/g body weight) (Wako) and insulin
(0.75mIU/g bodyweight) (Eli Lilly) in saline, respectively. Blood glucose concentrationsweremonitored at various time intervals using
a Medisafe-Mini blood glucose monitoring system (Terumo).
Oxygen consumption and locomotor activity
Oxygen consumption was measured every 3 min over 24 h under resting conditions using an MK-5000RQ metabolism measuring
system for small animals (Muromachi Kikai). For measurement of basal locomotor activity, mice were placed into chambers of an
ACTIMO-S food intake, drinking, and locomotor activity monitoring system (Shintechno). Food and water were provided ad libi-
tum. Mice were allowed to acclimatize in the chambers for 24 h, and then their physical activities were measured over the
next 24 h.
Immunoblotting
Tissues (100 mg) were soaked in 500 mL of RIPA buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% (w/v) sodium
deoxycholate, 0.1% SDS, 1 mM EDTA, 10 mM NaF, cOmplete protease inhibitors (Roche) and PhosSTOP phosphatase inhib-
itors (Roche), and then homogenized with a Precellys Evolution tissue homogenizer (Bertin). The homogenates (20 mg protein
equivalents) were subjected to SDS-PAGE on 10% (w/v) gels under reducing conditions with 2-mercaptoethanol. Protein con-
centrations were determined with a BCA protein assay kit (Thermo Fisher Scientific) using bovine serum albumin (BSA; Sigma-
Aldrich) as a standard. The separated proteins were electroblotted onto PVDF membranes (Millipore) with a semi-dry blotter
(Transblot SD; Bio-Rad). After blocking with 5% (w/v) skim milk in 10 mM Tris-HCl (pH 7.4) containing 150 mM NaCl (TBS)
and 0.1% (v/v) Tween 20 (TBS-T), the membranes were probed with rabbit antibody against Akt (C67E7; Cell Signaling) or phos-
phorylated Akt (p-Akt) Ser473 (D9E; Cell Signaling) at 1:1,000 dilution in TBS-T for 2 h, followed by incubation with horseradish
peroxidase-conjugated anti-rabbit IgG (AP156P; Millipore) at 1:5,000 dilution in TBS-T for 2 h, and then visualized using the ECL
Prime western blotting detection reagent (GE Healthcare). The signal intensities of p-Akt versus Akt were evaluated by densi-
tometric analysis (Fusion Solo S; Vilber-Lourmat).
CT analysis
Mice were anesthetized with somnopentyl (0.5 mg/g body weight) (Kyoritsu Seiyaku) and their adiposity was analyzed using Latheta
LCT-100 (Aloka).
Histology and immunohistochemistry
Mouse tissues were fixed with 100 mM phosphate buffer (pH 7.2) containing 4% (w/v) paraformaldehyde, embedded in paraffin,
sectioned, mounted on glass slides, deparaffinized in xylene, and rehydrated in ethanol with increasing concentrations of water.
Hematoxylin and eosin staining was performed on the 5-mm-thick cryosections, and the stained sections were analyzed using aCell Reports 31, 107579, May 5, 2020 e4
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OPEN ACCESSBZ-X710microscope (Keyence). Expression of UCP1 protein was assessed by immunostaining of deparaffinizedWAT sections using
rabbit polyclonal antibody against mouse UCP1 (ab10983, Abcam) and an EnVisionTM Detection System (Dako).
Whole mount immunofluorescence microscopy of adipose tissue
MouseWATwas fixed with 100 mL of 4% (w/v) paraformaldehyde for 3 h in a 96-well plate, washed with PBS, and treated with 200 mL
of 0.4% (v/v) Triton X-100 (Sigma) in PBSovernight at room temperature for permeabilization. After washing, the tissuewas incubated
with 100 mL of 5% (w/v) BSA in PBS (PBS-BSA) for blocking. After washing with PBS, the tissue was treated with rabbit anti-mouse
PLA2G2D antibody (Miki et al., 2013) in PBS-BSA (1:400 dilution) at 4C overnight, washed, and then treated with Alexa Fluor 555-
conjugated goat anti-rabbit IgG (A27039, Thermo Fisher Scientific) in PBS-BSA (1:400 dilution) for 2 h at room temperature. After
washing with PBS, the tissue was treated with rat anti-mouse F4/80 antibody (MCA497GA, Bio-Rad) or anti-mouse CD206 antibody
(MCA2235XZ, Bio-Rad) in PBS-BSA (1:100 dilution) at 4C overnight, washed, and then incubated with FITC-conjugated anti-rat IgG
(F6258, Sigma-Aldrich) in PBS-BSA (1:400 dilution) for 2 h at room temperature. After washing, the tissue was counterstained with
40,6-diamidine-20-phenylindole dihydrochloride (DAPI) (5 mg/ml) for 10 min, washed, and then analyzed using a confocal laser micro-
scopy (A1 HD25; Nikon).
Isolation of SVF
Adipose tissues were excised and minced in Hank’s solution with 0.5% (w/v) BSA. After centrifugation at 800g for 5 min, the floating
pieces of adipose tissue were incubated at 37C for 30 min in 1 mg/ml collagenase type II (Worthington) in Hank’s solution with
shaking. The suspension was filtered through a 70-mm cell strainer (BD Biosciences) and then centrifuged at 800g for 5 min to sepa-
rate floating adipocytes from the SVF pellet. After washes, the SVF pellet was suspended in red blood cell-lysing buffer and incubated
for 5 min on ice.
Flow cytometry
The isolated SVF cells were incubated with TruStain fcX (anti-mouse CD16/32) (BioLegend) for blocking, incubated with either
labeled monoclonal antibody or isotype control antibody (hamster IgG (HTK888), rat IgG2a (RTK2758) or rat IgG2b (RTK4530); Bio-
Legend), and analyzed by flow cytometry with a FACSAria III (BD Biosciences) and FlowJo (Tree Star) software. The antibodies
used were specific for mouse F4/80 (BM8, BioLegend), CD11b (M1/70, BioLegend), CD11c (N418, Thermo Fisher Scientific),
CD206 (C068C2, BioLegend), Sca1 (D7, BD PharMingen), CD45 (30-F11, Thermo Fisher Scientific), CD11b (M1/70, Biolegend),
B220 (RA3-6B2, BD PharMingen), and Ly6G (Gr1) (RB6-8C5, BD PharMingen).
Measurement of serum markers
Serum insulin and leptin levels were quantified by a mouse insulin ELISA kit (Morinaga) and a leptin immunoassay kit (R&D Systems),
respectively. Serum ALT levels were quantified using the transaminase CII-test Wako kit (Wako). Plasma FGF21 levels were deter-
mined using Mouse/Rat FGF-21 Quantikine ELISA Kit (R&D Systems). Analysis of plasma lipoproteins was performed by LipoSearch
(Skylight Biotech).
Lipidomics analysis
Lipidomics (ESI-MS) was performed in accordance with our current protocol (Miki et al., 2013; Yamamoto et al., 2015). In brief, for
detection of phospholipids, tissues were soaked in 10 volumes of 20 mM Tris-HCl (pH 7.4) and homogenized with a Polytron homog-
enizer. Lipids were extracted from the homogenates by the method of Bligh and Dyer (Yamamoto et al., 2015). MS analysis was
performed using a 4000Q-TRAP quadrupole-linear ion trap hybrid mass spectrometer (AB Sciex) with liquid chromatography (LC;
NexeraX2 system; Shimazu). The samples were applied to a Kinetex C18 column (1 3 150 mm i.d., 1.7 mm particle) (Phenomenex)
coupled to ESI-MS/MS. The samples injected by an autosampler (10 ml) were separated by a step gradient with mobile phase A
(acetonitrile/methanol/water = 1:1:1 [v/v/v] containing 5 mM phosphoric acid and 1 mM ammonium formate) and mobile phase B
(2-propanol containing 5 mM phosphoric acid and 1 mM ammonium formate) at a flow rate of 0.2 ml/min at 50C. For detection of
fatty acids and their oxygenated metabolites, tissues were soaked in 10 volumes of methanol and then homogenized with a Polytron
homogenizer. After overnight incubation at20C, water was added to the mixture to give a final methanol concentration of 10% (v/
v). The samples in 10%methanol were applied to Oasis HLB cartridges (Waters), washed with 10 mL of hexane, eluted with 3 mL of
methyl formate, dried under N2 gas, and dissolved in 60% methanol. The samples were then applied to a Kinetex C18 column (1 3
150 mm i.d., 1.7 mm particles) (Phenomenex) coupled to ESI-MS/MS as described above. The samples injected by an autosampler
(10 ml) were separated using a step gradient withmobile phase C (water containing 0.1% (v/v) acetic acid) andmobile phase D (aceto-
nitrile/methanol = 4:1; v/v) at a flow rate of 0.2ml/min at 45C. Identification was conducted usingmultiple reactionmonitoring (MRM)
transition and retention times, and quantification was performed based on the peak area of the MRM transition and the calibration
curve obtained with an authentic standard for each compound. As internal standards, d5-labeled EPA (1 nmol; Cayman Chemicals)
and LPC17:0 (1 nmol; Avanti Polar Lipids) were added to each sample.e5 Cell Reports 31, 107579, May 5, 2020
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All values are given as the mean ± SEM. Differences between two groups were assessed by using the unpaired two-tailed t test or
ANOVA Dunnett’s test using the Excel Statistical Program File yStat 2008 (Igaku Tosho Shuppan, Tokyo, Japan). Differences at P
values of less than 0.05 were considered statistically significant.
DATA AND CODE AVAILABILITY
The microarray data can be accessed at the GEO accession number GSE56038 (Sato et al., 2014).Cell Reports 31, 107579, May 5, 2020 e6
